Skip to main content
. 2021 Oct 31;61(3):387–400. doi: 10.1007/s40262-021-01071-5

Fig. 1.

Fig. 1

Pharmacokinetic model of intravenously administered inebilizumab. CL clearance, Kdec first-order rate constant describing the decrease of Vmax over time, Km concentration to achieve half of Vmax, Q intercompartmental clearance, Vc volume of distribution in the central compartment, Vmax maximum velocity of Michaelis–Menten equation, Vp volume of distribution in the peripheral compartment